Lin Cui

2.8k total citations
80 papers, 2.2k citations indexed

About

Lin Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lin Cui has authored 80 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 31 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Lin Cui's work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Cells and Metastasis (11 papers) and Virus-based gene therapy research (7 papers). Lin Cui is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Cancer Cells and Metastasis (11 papers) and Virus-based gene therapy research (7 papers). Lin Cui collaborates with scholars based in Japan, China and United States. Lin Cui's co-authors include Masao Tanaka, Kenoki Ohuchida, Kazuhiro Mizumoto, Naoki Ikenaga, Hayato Fujita, Kohei Nakata, Tadashi Kayashima, Shingo Kozono, Takao Ohtsuka and Kenji Fujiwara and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

In The Last Decade

Lin Cui

79 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Cui Japan 28 1.1k 921 679 329 281 80 2.2k
Hua Xiong China 27 1.4k 1.3× 882 1.0× 608 0.9× 280 0.9× 269 1.0× 52 2.4k
Yoko Matsuda Japan 27 1.0k 0.9× 944 1.0× 503 0.7× 163 0.5× 354 1.3× 163 2.3k
Jie Su China 17 1.8k 1.6× 663 0.7× 447 0.7× 229 0.7× 148 0.5× 32 2.6k
Stan Lightfoot United States 33 1.6k 1.5× 1.1k 1.2× 663 1.0× 277 0.8× 420 1.5× 107 3.0k
Fan Yao China 27 1.7k 1.6× 570 0.6× 1.1k 1.6× 269 0.8× 160 0.6× 99 2.8k
Kiyomu Fujii Japan 28 888 0.8× 380 0.4× 421 0.6× 221 0.7× 324 1.2× 75 1.9k
Xisong Ke China 20 1.3k 1.2× 533 0.6× 503 0.7× 247 0.8× 106 0.4× 54 2.0k
Minfeng Chen China 25 1.3k 1.1× 465 0.5× 607 0.9× 280 0.9× 278 1.0× 85 2.2k
Kuo‐Tai Hua Taiwan 30 1.7k 1.5× 492 0.5× 716 1.1× 293 0.9× 114 0.4× 62 2.3k
Meng‐Chi Yen Taiwan 27 1.1k 1.0× 466 0.5× 590 0.9× 417 1.3× 99 0.4× 81 2.0k

Countries citing papers authored by Lin Cui

Since Specialization
Citations

This map shows the geographic impact of Lin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Cui more than expected).

Fields of papers citing papers by Lin Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Cui. The network helps show where Lin Cui may publish in the future.

Co-authorship network of co-authors of Lin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Cui. A scholar is included among the top collaborators of Lin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Cui. Lin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asanoma, Kazuo, Hiroshi Yagi, Ichiro Onoyama, et al.. (2024). The BHLHE40‒PPM1F‒AMPK pathway regulates energy metabolism and is associated with the aggressiveness of endometrial cancer. Journal of Biological Chemistry. 300(3). 105695–105695. 1 indexed citations
2.
Wang, Youping, et al.. (2019). Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway. BMC Complementary and Alternative Medicine. 19(1). 198–198. 27 indexed citations
3.
Zheng, Biao, Kenoki Ohuchida, Ming Zhao, et al.. (2015). CD146 attenuation in cancer‐associated fibroblasts promotes pancreatic cancer progression. Molecular Carcinogenesis. 55(11). 1560–1572. 36 indexed citations
4.
Cui, Lin, Jue Chen, Min Wang, et al.. (2015). Analysis of Relationships Between Prethrombotic States and Cervical Cancer. Asian Pacific Journal of Cancer Prevention. 16(14). 6163–6166. 7 indexed citations
6.
Kozono, Shingo, Kenoki Ohuchida, Daiki Eguchi, et al.. (2013). Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells. Cancer Research. 73(7). 2345–2356. 173 indexed citations
7.
Jiang, Yong, et al.. (2012). The Prognostic Role of RASSF1A Promoter Methylation in Breast Cancer: A Meta-Analysis of Published Data. PLoS ONE. 7(5). e36780–e36780. 42 indexed citations
8.
Cui, Lin. (2011). Expression and clinical significance of BIM in non-small cell lung cancer with EGFR mutation. Journal of Shandong University. 1 indexed citations
9.
Zhao, Ming, Yohei Tominaga, Kenoki Ohuchida, et al.. (2011). Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer. Cancer Science. 103(1). 58–66. 26 indexed citations
10.
Sakai, Hiroshi, Kenoki Ohuchida, Kazuhiro Mizumoto, et al.. (2011). Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer. Annals of Surgical Oncology. 18(7). 2057–2065. 9 indexed citations
11.
Nakata, Kohei, Kenoki Ohuchida, Kazuhiro Mizumoto, et al.. (2011). MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery. 150(5). 916–922. 123 indexed citations
12.
Cui, Lin, Kenoki Ohuchida, Kazuhiro Mizumoto, et al.. (2010). Prospectively Isolated Cancer-Associated CD10+ Fibroblasts Have Stronger Interactions with CD133+ Colon Cancer Cells than with CD133− Cancer Cells. PLoS ONE. 5(8). e12121–e12121. 28 indexed citations
13.
Tsutsumi, Kosuke, Norihiro Sato, Lin Cui, et al.. (2010). Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. Modern Pathology. 24(4). 533–541. 14 indexed citations
14.
Fujita, Hayato, Kenoki Ohuchida, Kazuhiro Mizumoto, et al.. (2009). Tumor–stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Science. 100(12). 2309–2317. 62 indexed citations
15.
Yu, Jun, Kenoki Ohuchida, Kohei Nakata, et al.. (2008). LIM only 4 is overexpressed in late stage pancreas cancer. Molecular Cancer. 7(1). 93–93. 20 indexed citations
17.
Kawabe, Mayumi, Lin Cui, Naoya Kimoto, et al.. (2000). Modifying Effects of Propolis on MeIQx Promotion of Rat Hepatocarcinogenesis and in a Female Rat Two-Stage Carcinogenesis Model After Multiple Carcinogen Initiation. Nutrition and Cancer. 37(2). 179–186. 17 indexed citations
18.
19.
Mori, Toshio, Lin Cui, Koji Kato, et al.. (1996). Direct Effects of Testosterone, Dihydrotestosterone and Estrogen on 3,2′‐Dimethyl‐4‐aminobiphenyl‐induced Prostate Carcinogenesis in Castrated F344 Rats. Japanese Journal of Cancer Research. 87(6). 570–574. 6 indexed citations
20.
Hoshiya, Toru, Ryohei Hasegawa, Kazuo Hakoi, et al.. (1993). Enhancement by non-mutagenic pesticides of GST-P positive hepatic foci development initiated with diethylnitrosamine in the rat. Cancer Letters. 72(1-2). 59–64. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026